ES-cell derived hematopoietic cells induce transplantation tolerance

Area of Science:

• Stem cell biology
• Immunology
• Transplantation science

Background:

• Bone marrow cells induce transplantation tolerance but are highly immunogenic, requiring harsh preconditioning and immunosuppression.
• Embryonic stem (ES) cells offer a potential source of less immunogenic hematopoietic progenitor cells (HPCs).
• Generating stable hematopoietic cells from ES cells has been a significant challenge.

Purpose of the Study:

• To investigate the potential of HOXB4-transduced ES cell-derived HPCs for transplantation.
• To assess the immunogenicity and engraftment capacity of these ES-derived HPCs in allogeneic recipients.
• To evaluate the ability of ES-derived HPCs to induce tolerance and protect allografts without immunosuppression.

Main Methods:

• Derivation of CD45(+) HPCs from HOXB4-transduced ES cells.
• Assessment of MHC antigen expression on ES-derived HPCs.
• Engraftment studies in sublethally irradiated allogeneic recipients.
• Monitoring of chimerism in peripheral blood and bone marrow.
• Evaluation of cardiac allograft survival in chimeric animals.

Main Results:

• HOXB4-transduced ES cells yielded CD45(+) HPCs with low MHC antigen expression.
• These HPCs achieved long-term engraftment in allogeneic recipients without immunosuppressive agents.
• Stable, low-level bone marrow chimerism was maintained for over 100 days.
• Chimeric animals demonstrated protection against donor-type cardiac allograft rejection.

Conclusions:

• ES cell-derived CD45(+) HPCs can engraft in allogeneic recipients without immunosuppression.
• This approach represents a novel strategy for inducing transplantation tolerance.
• ES-derived HPCs offer a potential alternative to bone marrow transplantation, mitigating risks associated with immunogenicity and immunosuppression.